Article
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
METS-IR Predicts Cardiovascular Risk in Type 2 Diabetes
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
Technology Improves Glycemic Control in Type 1 Diabetes, but Disparities Widen
How Can Employers Leverage the DPP to Improve Diabetes Rates?
Trends in Insulin Out-of-Pocket Costs and Use Disparities, 2008-2021
PFAS Exposure Linked to Increased Risk of Type 2 Diabetes, Study Finds